Screening for Chlamydia trachomatis in Women 15 to 29 Years of Age: A Cost-Effectiveness Analysis
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Clinical guidelines have traditionally advised annual Chlamydia trachomatis screening for women younger than 25 years of age. OBJECTIVE: To assess the cost-effectiveness of recently proposed strategies for chlamydia screening. DESIGN: State transition simulation model; cost-effectiveness analysis. DATA SOURCES: Published literature. TARGET POPULATION: Sexually active U.S. women 15 to 29 years of age. TIME HORIZON: Lifetime. PERSPECTIVE: Modified societal. INTERVENTIONS: Four strategies targeted to 3 specific age groups (15 to 19 years, 15 to 24 years, and 15 to 29 years): 1) no screening, 2) annual screening for all women, 3) annual screening followed by 1 repeated test within 3 to 6 months after a positive test result, and 4) annual screening followed by selective semiannual screening for women with a history of infection. OUTCOME MEASURES: Clinical events (for example, pelvic inflammatory disease, chronic pelvic pain, ectopic pregnancy, and infertility), lifetime costs, quality-adjusted life expectancy, and incremental cost-effectiveness ratios. RESULTS OF BASE-CASE ANALYSIS: Annual screening in women 15 to 29 years of age followed by semiannual screening for those with a history of infection was the most effective and cost-effective strategy. It consistently had an incremental cost-effectiveness ratio less than 25,000 dollars per quality-adjusted life-year (QALY) compared with the next most effective strategy. When the indirect transmission effects of a 10-year screening program on the probability of infection in uninfected women (that is, per-susceptible rate of infection) were considered, all strategies became more cost-effective. RESULTS OF SENSITIVITY ANALYSIS: Results were sensitive to the annual incidence of chlamydia, probability of persistent infection, screening test costs, and costs of treating long-term complications. Each variable was associated with threshold values beyond which screening became cost-saving. In probabilistic analysis, annual screening in women 15 to 29 years of age followed by semiannual screening for those with a history of infection had an incremental cost-effectiveness ratio less than 50,000 dollars per QALY in 99% of simulations. LIMITATIONS: Uncertainty about the natural history of chlamydial infection and consideration of only the indirect transmission effects of C. trachomatis screening. CONCLUSIONS: Annual C. trachomatis screening for all women 15 to 29 years of age and selective targeting of those with a history of infection for semiannual screening is very cost-effective compared with other well-accepted clinical interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection
Scholes, D., Stergachis, A., Heidrich, F. E., Andrilla, H., Holmes, K. K., & Stamm, W. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342103 · Cited by 847
The Estimated Direct Medical Cost of Sexually Transmitted Diseases Among American Youth, 2000
Chesson, H. W., Blandford, J. M., Gift, T. L., Tao, G., & Irwin, K. L. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3601104 · Cited by 444
Use of infertility services in the United States: 1995
Stephen, E. H., & Chandra, A. (2000) · Family Planning Perspectives · doi:10.2307/2648162 · Cited by 166
KATZ, B. P., DANOS, C. S., QUINN, T. S., CAINE, V., & JONES, R. B. (1988) · Sexually Transmitted Diseases · doi:10.1097/00007435-198801000-00003 · Cited by 75
Cited by
Price, M. J., Ades, A., Soldan, K., Welton, N. J., Macleod, J., Simms, I., DeAngelis, D., Turner, K. M., & Horner, P. J. (2016) · Health Technology Assessment · doi:10.3310/hta20220 · Cited by 494
A public health focus on infertility prevention, detection, and management
Macaluso, M., Wright-Schnapp, T. J., Chandra, A., Johnson, R., Satterwhite, C. L., Pulver, A., Berman, S. M., Wang, R. Y., Farr, S. L., & Pollack, L. A. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.09.046 · Cited by 286
Peterman, T. A., Tian, L. H., Metcalf, C. A., Satterwhite, C. L., Malotte, C. K., DeAugustine, N., Paul, S. M., Cross, H., Rietmeijer, C. A., Douglas, J. M., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-8-200610170-00005 · Cited by 181
Cost-effectiveness of opt-out chlamydia testing for high-risk young women in the U.S.
Owusu-Edusei, K., Hoover, K. W., & Gift, T. L. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.01.007 · Cited by 31
Metadata
- Authors
- Hu, D., Hook, E. W., & Goldie, S. J.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2004-10-05
- Volume
- 141
- Issue
- 7
- Pages
- 501-513
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1967050052
- Cited by
- 140
- References
- 4
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening for Chlamydia trachomatis in Women 15 to 29 Years of Age: A Cost-Effectiveness Analysis. https://app.cochat.ai/papers/10.7326/0003-4819-141-7-200410050-00006
- The paper
- Hu, D., Hook, E. W., & Goldie, S. J. (2004). Screening for Chlamydia trachomatis in Women 15 to 29 Years of Age: A Cost-Effectiveness Analysis. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-141-7-200410050-00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.